December 30, 2025 • On the last episode of All Songs Considered for 2025, NPR Music producer Lars Gotrich takes host Robin Hilton through an exceptional year in guitar music. From Gwenifer Raymond's ...
Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback